2 assets in Acute Myeloid Leukemia With CEBPA Somatic Mutations

Therapeutic assets addressing Acute Myeloid Leukemia With CEBPA Somatic Mutations, rated under Floatz methodology v0.2 and sorted by current rating.

Asset	Sponsor	Phase	Rating
Cytarabine Acute Myeloid Leukemia With CEBPA Somatic Mutations	The First Affiliated Hospital of Soochow University	P1/2	CCC (48)
Venetoclax Acute Myeloid Leukemia With CEBPA Somatic Mutations	The First Affiliated Hospital of Soochow University	P1/2	CCC (48)